» Authors » Ana Alcaraz-Serna

Ana Alcaraz-Serna

Explore the profile of Ana Alcaraz-Serna including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 350
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pacesa M, Nickel L, Schellhaas C, Schmidt J, Pyatova E, Kissling L, et al.
bioRxiv . 2024 Dec; PMID: 39677777
Protein-protein interactions (PPIs) are at the core of all key biological processes. However, the complexity of the structural features that determine PPIs makes their design challenging. We present BindCraft, an...
2.
Alcaraz-Serna A, Porret R, Trueb L, Ribi C, Seebach J, Muller Y
Rev Med Suisse . 2024 Apr; 20(868):688-693. PMID: 38568061
Cellular therapy using genetically modified T lymphocytes expressing synthetic receptors, known as CAR (Chimeric Antigen Receptor), has revolutionized the treatment of certain hematologic malignancies. This success has led to exploring...
3.
Fallet B, Foglierini M, Porret R, Alcaraz-Serna A, Sauvage C, Jenelten R, et al.
J Infect . 2023 Jun; 87(2):111-119. PMID: 37321353
Objectives: Intradermal skin test (IDT) with mRNA vaccines may represent a simple, reliable, and affordable tool to measure T cell response in immunocompromised patients who failed to mount serological responses...
4.
Alcaraz-Serna A, Noto A, Ermellino L, Monzambani-Banderet V, Tommasini F, Stehlin F, et al.
Allergol Int . 2023 Apr; 72(4):600-603. PMID: 37061390
No abstract available.
5.
Lopez-Ayala P, Alcaraz-Serna A, Valls Carbo A, Cuadrado Cenzual M, Torrejon Martinez M, Picado A, et al.
Emergencias . 2022 Mar; 34(2):119-127. PMID: 35275462
Objectives: Although many demographic and clinical predictors of mortality have been studied in relation to COVID-19, little has been reported about the prognostic utility of inflammatory biomarkers. Material And Methods:...
6.
Alcaraz-Serna A, Bustos-Moran E, Fernandez-Delgado I, Calzada-Fraile D, Torralba D, Marina-Zarate E, et al.
Sci Adv . 2021 Feb; 7(6). PMID: 33536205
Understanding the fate of dendritic cells (DCs) after productive immune synapses (postsynaptic DCs) with T cells during antigen presentation has been largely neglected in favor of deciphering the nuances of...
7.
Marcos-Jimenez A, Sanchez-Alonso S, Alcaraz-Serna A, Esparcia L, Lopez-Sanz C, Sampedro-Nunez M, et al.
Eur J Immunol . 2020 Nov; 51(3):634-647. PMID: 33251605
SARS-CoV-2 infection causes an abrupt response by the host immune system, which is largely responsible for the outcome of COVID-19. We investigated whether the specific immune responses in the peripheral...
8.
Galvan-Roman J, Rodriguez-Garcia S, Roy-Vallejo E, Marcos-Jimenez A, Sanchez-Alonso S, Fernandez-Diaz C, et al.
J Allergy Clin Immunol . 2020 Oct; 147(1):72-80.e8. PMID: 33010257
Background: Patients with coronavirus disaese 2019 (COVID-19) can develop a cytokine release syndrome that eventually leads to acute respiratory distress syndrome requiring invasive mechanical ventilation (IMV). Because IL-6 is a...
9.
Sanchez-Cerrillo I, Landete P, Aldave B, Sanchez-Alonso S, Sanchez-Azofra A, Marcos-Jimenez A, et al.
J Clin Invest . 2020 Aug; 130(12):6290-6300. PMID: 32784290
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in infected individuals, who can either exhibit mild symptoms or progress toward a life-threatening acute respiratory distress syndrome (ARDS)....
10.
Sanchez-Cerrillo I, Landete P, Aldave B, Sanchez-Alonso S, Sanchez-Azofra A, Marcos-Jimenez A, et al.
medRxiv . 2020 Jun; PMID: 32511573
The SARS-CoV-2 is responsible for the pandemic COVID-19 in infected individuals, who can either exhibit mild symptoms or progress towards a life-threatening acute respiratory distress syndrome (ARDS). It is known...